Authors' reply to Braillon and Bewley, Spiller and colleagues, and Wu

BMJ. 2019 Sep 23:366:l5622. doi: 10.1136/bmj.l5622.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cannabinoids*
  • Female
  • Humans
  • Hyperemesis Gravidarum*
  • Pregnancy
  • Syndrome

Substances

  • Cannabinoids